Optimal length transportation hypothesis to model proteasome product size distribution

scientific article published on 26 October 2006

Optimal length transportation hypothesis to model proteasome product size distribution is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S10867-006-9014-Z
P932PMC publication ID2651524
P698PubMed publication ID19669465
P5875ResearchGate publication ID26731031

P50authorAlexey ZaikinQ41050034
P2093author name stringJuergen Kurths
P2860cites workKinetic characterization of the chymotryptic activity of the 20S proteasome.Q52306880
Atomic force microscopy reveals two conformations of the 20 S proteasome from fission yeastQ57752879
The 19 S multicatalytic "prosome" proteinase is a constitutive enzyme in HeLa cellsQ69845293
Processive degradation of proteins and other catalytic properties of the proteasome from Thermoplasma acidophilumQ71985039
Existence of a molecular ruler in proteasomes suggested by analysis of degradation productsQ72106975
Evidence for the existence of a non-catalytic modifier site of peptide hydrolysis by the 20 S proteasomeQ73778113
Range of sizes of peptide products generated during degradation of different proteins by archaeal proteasomesQ74088744
Decelerated degradation of short peptides by the 20S proteasomeQ77317960
Resonantly driven Brownian motion: Basic concepts and exact resultsQ77845174
Processive Motor Protein as an Overdamped Brownian StepperQ79283969
The ubiquitin-proteasome proteolytic pathway: destruction for the sake of constructionQ24292709
Structure and functions of the 20S and 26S proteasomesQ24328777
26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptideQ24535312
Ubiquitin-dependent protein degradationQ27931143
The axial channel of the proteasome core particle is gated by the Rpt2 ATPase and controls both substrate entry and product releaseQ27933726
The transporter associated with antigen processing: function and implications in human diseasesQ28214433
The ubiquitin-proteasome proteolytic pathwayQ29618638
Cleavage motifs of the yeast 20S proteasome beta subunits deduced from digests of enolase 1.Q32000515
Producing nature's gene-chips: the generation of peptides for display by MHC class I moleculesQ32063827
Interruption of tumor cell cycle progression through proteasome inhibition: implications for cancer therapy.Q33194417
Degradation of cell proteins and the generation of MHC class I-presented peptidesQ33652524
The role of the ubiquitin-proteasome pathway in apoptosisQ33669467
The proteasome activator 11 S REG (PA28) and class I antigen presentationQ33796158
Proteasome inhibition: a new strategy in cancer treatmentQ33945453
Ubiquitin-dependent proteolysis: its role in human diseases and the design of therapeutic strategiesQ34152646
Antigen processing by the proteasomeQ34193262
The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides.Q34801799
Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII.Q35821221
The proteasome and MHC class I antigen processingQ35967572
Structural features of the 26 S proteasome complexQ39405119
A kinetic model of vertebrate 20S proteasome accounting for the generation of major proteolytic fragments from oligomeric peptide substratesQ40169547
Protein-protein ratchets: stochastic simulation and application to processive enzymesQ40189648
A mathematical model of protein degradation by the proteasomeQ40324090
Proteasomes of the yeast S. cerevisiae: genes, structure and functionsQ40416393
An algorithm for the prediction of proteasomal cleavagesQ40768749
Kinetic evidences for facilitation of peptide channelling by the proteasome activator PA28.Q40851962
Nanoenzymology of the 20S proteasome: proteasomal actions are controlled by the allosteric transitionQ42677060
Modelling the human immune system by combining bioinformatics and systems biology approachesQ43168249
Prediction of proteasome cleavage motifs by neural networksQ43976304
Assessment of proteasomal cleavage probabilities from kinetic analysis of time-dependent product formationQ44021101
Proline- and arginine-rich peptides constitute a novel class of allosteric inhibitors of proteasome activityQ44520195
Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I bindingQ46469492
The first characterization of a eubacterial proteasome: the 20S complex of RhodococcusQ48072601
Proteasomal activity in brain differs between species and brain regions and changes with age.Q48890478
P433issue3-4
P304page(s)231-243
P577publication date2006-10-26
P1433published inJournal of Biological PhysicsQ2075911
P1476titleOptimal length transportation hypothesis to model proteasome product size distribution
P478volume32

Reverse relations

cites work (P2860)
Q42122935Force spectroscopy of substrate molecules en route to the proteasome's active sites
Q33912642Modelling proteasome and proteasome regulator activities.